Category: <span>VS-5584</span>

Category: VS-5584

alimta, COMMAND, Data Safety Monitoring Board, Defactinib, focal adhesion kinase, Joseph Pantgins, Lou Vaickus, malignant pleural mesothelioma, mesothelioma clinical trials, Mesothelioma News, Robert Forrester, Verastem, VS-4718, VS-5584, VS-6063

Verastem Mesothelioma Clinical Trial Stopped Early For Futility

 

The Boston-based company Verastem has stopped its mesothelioma clinical trial early due to futile results in the Phase 2 study of VS-6063.